Sequoia Capital36 min
Jawbone: The Rise and Fall of the First Wearable Technology Company
- Success in the next decade is contingent upon sound fundamentals and operating rigor.
- New startups are expected to derive valuable insights to construct future market-leading companies.
- Initial wireless Jawbone headsets were anticipated to sell out immediately due to craftsmanship and attention to detail.
- The Jambox product was projected to generate 80% market share until competitor entry eroded price points and margins.
- Product differentiation for the Jambox was expected to rely on superior sound quality and expressive design against static industry competitors.
- Sales for the Jambox were planned to leverage the mobile phone revolution to reach an existing customer base of mobile operators.
- The team believed internal intuition would mitigate the risks associated with innovating a new product category.
- Revenue stickiness was expected to be achieved by establishing ownership of a music service, despite not currently possessing one.
- Market dynamics for wearable technology were predicted to mirror the predictable demand observed in speakers and headsets.
- The Up bracelet was expected to achieve category-breaking success following a positive reception at TED Global.
- A durable, fixed version of the Up bracelet was targeted for release in late 2012 to resolve prior recall issues.
- Short-term debt financing was planned to fund inventory needs and resolve cash constraints prior to an equity round.
- A larger equity offer was expected to provide sufficient capital to address P&L gaps and open orders.
- A final equity round was anticipated to fully fund the amount intended to restore the business to a growth trajectory, though this funding ultimately did not materialize.
- The business was expected to become self-sustaining if it had executed difficult decisions to rebuild the organization from scratch.
- Success was projected if the company had delivered reliable products with strong margins rather than operating as a low-margin, capital-intensive entity.
- Failure to align company valuation with actual financial reality was expected to create significant investor conflict.
- The board's delayed communication regarding the potential negative outcome contributed to the eventual failure.
- Future investors are expected to become more risk-averse following the company's collapse.
- Breakthrough R&D from Jawbone is anticipated to have directly led to the founding of All.Health.
- Lessons from the failure are expected to result in better handling of difficult conversations in future ventures.
- Future advising is expected to be ruthless regarding specific past mistakes, including overvaluation and low gross margins in capital-intensive sectors.